The Metrix blog
Agility in action: How pharma teams can thrive through disruption
Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges are steeper. Market disruptions, mergers and acquisitions,…
Metrix's top picks
Why pharma training needs a new playbook for rare disease
The rare disease sector is no longer a niche. Nearly half of all new drug approvals in the U.S. now address rare or orphan indications. These therapies bring enormous promise but also expose how outdated most commercial training models still are. For decades, pharma L&D teams have built their programs around scale: large field forces, broad awareness campaigns,…
The experiential edge: Why learning by doing drives behavior change
If you’ve ever tried to learn to swim from a…
Storytelling with purpose: Using patient narratives to transform pharma training
In pharma, facts and data are everywhere. Clinical results, safety…
Why intelligent personalization is the future of pharma L&D
In pharma, training has never been “one-size-fits-all.” Your sales rep…
Stay ahead of the game with regular updates
All results
Agility in action: How pharma teams can thrive through disruption
Change isn’t coming to pharma, it’s already here. Product lifecycles are shorter. Access challenges are steeper. Market disruptions, mergers and acquisitions,…
Why pharma training needs a new playbook for rare disease
The rare disease sector is no longer a niche. Nearly half of all new drug approvals in the U.S….
The experiential edge: Why learning by doing drives behavior change
If you’ve ever tried to learn to swim from a manual, you know it doesn’t work. You…
Storytelling with purpose: Using patient narratives to transform pharma training
In pharma, facts and data are everywhere. Clinical results, safety data, prescribing guidelines, these are essential, but…
Why intelligent personalization is the future of pharma L&D
In pharma, training has never been “one-size-fits-all.” Your sales rep in oncology needs a very different learning…
From learning to business impact: Closing the measurement gap in pharma training
Pharma leaders know training is a critical investment. Whether it’s onboarding new hires, preparing a field team for launch,…
From passive to performance: Our 4-step method to drive lasting behavior change
In pharma, knowing isn’t enough. Performance happens when knowledge turns into action and that’s where most training…
A smarter way to turn strategic priorities into measurable impact
In pharma, the stakes are high. Brand teams chase ambitious goals, while training teams are tasked with…
Why less is more in training: Maximizing ROI under budget constraints
In life sciences, learning and development leaders are navigating a new set of pressures. Teams are expected…
6 Common pitfalls of L&D in pharma and what to do instead
Creating learning programs in the life sciences space is high-stakes. Whether you’re supporting sales teams preparing for…
Emerging digital trends in pharma marketing
In the rapidly evolving pharmaceutical and life sciences sectors, omnichannel marketing has become a pivotal strategy for…
Human + AI in pharma marketing and training: The hybrid approach that’s changing the game
Artificial Intelligence (AI) is no longer a futuristic concept; it’s here, and it’s transforming how life sciences…